5-Symptom Digestive Relief
NDC 11673-291, Bismuth Subsalicylate, suspension, from TARGET CORPORATION.
- Product NDC
- 11673-291
- Status
- Listed
- Labeler
- TARGET CORPORATION
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M008
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/11673-291 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BISMUTH SUBSALICYLATE525 mg/30mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 11673-291-06 | 11673029106 | 236 mL in 1 BOTTLE, PLASTIC (11673-291-06) |
| 11673-291-07 | 11673029107 | 473 mL in 1 BOTTLE, PLASTIC (11673-291-07) |
| 11673-291-08 | 11673029108 | 2 BOTTLE, PLASTIC in 1 PACKAGE (11673-291-08) / 473 mL in 1 BOTTLE, PLASTIC (11673-291-07) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 11673-291 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/11673-291 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 11673-291. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.